strenuus marketing s a s

Activity value 89 International Buyer&Supplier,Last transaction date: 2026-01-15 Address: cl 77 65 37 lc 178

Overview
Contact
Import data
Partners
HS Codes
Products
Areas
Ports

Trade trend analysis

Mon | Year

Number of Transactions Quantity Weight

The above chart presents the market trend analysis for strenuus marketing s a s from 2025 to 2026. By examining various dimensions such as transaction quantity, transaction weight, average price, and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability. As of 2026, the company has completed 1 transactions, with a transaction quantity of 19.52 and a transaction weight of 19.52.

Year Transactions Quantity Weight
2025 15 9498.52 4489.52
2026 1 19.52 19.52

Bill of lading data

< 1/15 >

Trade date 2026/01/15 B/L No. 92003004587968
Suppliers qalys pharmaceutical llc Buyers strenuus marketing s a s
POLs —— PODs bogota
Supply area United States Purchas area Colombia
Weight 19.52kg Amount 19764
Hs code 3002151000 Product tags immunological products
Product description DO 2600155 PEDIDO TRAMITE: BLR8093504 DECLARACION(1-1) REGISTRO DE IMPORTACION NO. REG-50006722-20260114N CON FECHA: 202 Expand

Trade date 2025/12/24 B/L No. 92003008715451
Suppliers qalys pharmaceutical llc Buyers strenuus marketing s a s
POLs —— PODs bogota
Supply area United States Purchas area Colombia
Weight 41.7kg Amount 45036
Hs code 3002151000 Product tags immunological products
Product description DO 2523690 PEDIDO TRAMITE: FULPHILA DECLARACION(1-1) DECLARACIÓN DE LEGALIZACIÓN MERCANCÍA NO AMPARADA EN EL DOCUMENTO D Expand

Trade date 2025/12/17 B/L No. 92003009987825
Suppliers qalys pharmaceutical llc Buyers strenuus marketing s a s
POLs —— PODs bogota
Supply area United States Purchas area Colombia
Weight 288.9kg Amount 42000
Hs code 3002121900 Product tags antisera
Product description DO 2522617 PEDIDO TRAMITE: INMUNOGLOBULINA ZF DECLARACION(1-1) REGISTRO DE IMPORTACION NO. REG-50229037-20251204N CON FE Expand

Trade date 2025/12/17 B/L No. 92003009987746
Suppliers qalys pharmaceutical llc Buyers strenuus marketing s a s
POLs —— PODs bogota
Supply area United States Purchas area Colombia
Weight 1255.5kg Amount 189800
Hs code 3002121900 Product tags antisera
Product description DO 2522617 PEDIDO TRAMITE: INMUNOGLOBULINA ZF DECLARACION(1-1) REGISTRO DE IMPORTACION NO. REG-50229037-20251204N CON FE Expand

Trade date 2025/12/10 B/L No. 92003009779197
Suppliers qalys pharmaceutical llc Buyers strenuus marketing s a s
POLs —— PODs bogota
Supply area United States Purchas area Colombia
Weight 659.56kg Amount 758582
Hs code 3002151000 Product tags immunological products
Product description DO 2522722 PEDIDO TRAMITE: 235-30778016 DECLARACION(1-1) REGISTRO DE IMPORTACION NO. REG-50232351-20251209N CON FECHA: 2 Expand

Trade date 2025/09/26 B/L No. 6780973
Suppliers bharat serums&vaccines ltd. Buyers strenuus marketing s a s
POLs bombay air cargo PODs bogota
Supply area India Purchas area Colombia
Weight —— Amount 0.00008715
Hs code 30021290 Product tags integra,mean
Product description (TAX INV. NO.9089008285 DT. 25.09.2025) (SUPPLY MEANT FOR EXPORT ON PAYMENT OF INTEGRATED TAX) Expand

Trade date 2025/09/26 B/L No. 6780973
Suppliers bharat serums&vaccines ltd. Buyers strenuus marketing s a s
POLs bombay air cargo PODs bogota
Supply area India Purchas area Colombia
Weight —— Amount 19150519.66
Hs code 30021290 Product tags norma,immunoglobulin,human,intravenous,gamma
Product description GAMMA IV 5 GM [NORMAL IMMUNOGLOBULIN FOR INTRAVENOUS USE (HUMAN)] Expand

Trade date 2025/09/22 B/L No. 92003007380658
Suppliers qalys pharmaceutical llc Buyers strenuus marketing s a s
POLs —— PODs bogota
Supply area United States Purchas area Colombia
Weight 646kg Amount 269100
Hs code 3002121900 Product tags antisera
Product description DO 2517244 PEDIDO TRAMITE: A03325001 DECLARACION(1-1) REGISTRO DE IMPORTACION N. REG-50174276-20250918N, FECHA APROBACIO Expand

Trade date 2025/09/01 B/L No. 5041995
Suppliers bharat serums&vaccines ltd. Buyers strenuus marketing s a s
POLs bombay air cargo PODs bogota
Supply area India Purchas area Colombia
Weight —— Amount 22150601.09
Hs code 30021290 Product tags norma,immunoglobulin,human,intravenous,gamma
Product description GAMMA IV 5 GM [NORMAL IMMUNOGLOBULIN FORINTRAVENOUS USE (HUMAN) [GAMMA IV 5%] Expand

Trade date 2025/07/17 B/L No. 92003005503764
Suppliers qalys pharmaceutical llc Buyers strenuus marketing s a s
POLs —— PODs bogota
Supply area United States Purchas area Colombia
Weight 266.53kg Amount 274882
Hs code 3002151000 Product tags immunological products
Product description DO 2512671 PEDIDO TRAMITE: FULPHILA BF25000397 DECLARACION(1-1) ACTA DE REEMPAQUE N. 2025137502, FECHA: 2025-06-16.. (IT Expand

Trade date 2025/07/17 B/L No. 92003005506214
Suppliers qalys pharmaceutical llc Buyers strenuus marketing s a s
POLs —— PODs bogota
Supply area United States Purchas area Colombia
Weight 240kg Amount 284000
Hs code 3002151000 Product tags immunological products
Product description DO 2512672 PEDIDO TRAMITE: BF25001868 DECLARACION(1-1) ACTA DE REEMPAQUE NO. 2025137816, FECHA: 2025-07-04.. (ITEM 1) MC Expand

Trade date 2025/05/27 B/L No. 92003004082981
Suppliers qalys pharmaceutical llc Buyers strenuus marketing s a s
POLs —— PODs bogota
Supply area United States Purchas area Colombia
Weight 360kg Amount 255000
Hs code 3002151000 Product tags immunological products
Product description DO 2508676 PEDIDO TRAMITE: 1065810304 DECLARACION 2-2 DECLARACI N DE LEGALIZACI N MERCANC A NO AMPARADA EN EL DOCUMENTO DE TRANSPORTE, CONFORME AL ART. 78, 79 Y 80 DE LA RESOLUCI N 000046 DE 2019 ACTA DE REEMPAQUE NO. 2025136188 DE 2025-04-04. ITEM 2OGIVRI-TRASTUZUMAB 44 MG MCIA DE PRIMERA CALIDAD. NOMBRE DEL PRODUCTO: OGIVRI; NOMBRE DEL PRINCIPIO ACTIVO: TRASTUZUMAB, CONCENTRACION: CADA VIAL CONTIENE 440 MG DE TRASTUZUMAB, INDICACIONES Y O USO TERAP UTICO: C NCER DE MAMA C NCER DE MAMA METAST SICO CMM : OGIVRI TRASTUZUMAB EST INDICADO PARA EL TRATAMIENTO DE PACIENTES CON CMM CON SOBREEXPRESI N DE HER2: EN MONOTERAPIA EN LOS QUE HAYAN RECIBIDO PREVIAMENTE UNO O M S REG MENES DE QUIMIOTERAPIA COMO TRATAMIENTO DEL C NCER METAST SICO; EN COMBINACI N CON PACLITAXEL O DOCETAXEL EN LOS QUE NO HAYAN RECIBIDO PREVIAMENTE QUIMIOTERAPIA COMO TRATAMIENTO DEL C NCER METAST SICO; EN COMBINACI N CON UN INHIBIDOR DE LA AROMATASA PARA EL TRATAMIENTO DE PACIENTES CON CMM CON RECEPTORES HORMONALES. C NCERDE MAMA PRECOZ CMP : Expand

Trade date 2025/05/27 B/L No. 92003004082999
Suppliers qalys pharmaceutical llc Buyers strenuus marketing s a s
POLs —— PODs bogota
Supply area United States Purchas area Colombia
Weight 140kg Amount 164500
Hs code 3002151000 Product tags immunological products
Product description DO 2508676 PEDIDO TRAMITE: 1065810304 DECLARACION 1-2 ACTA DE REEMPAQUE NO. 2025136188 DE 2025-04-04. ITEM 1 MERCANCIA NUEVA, C DIGO IUM:1B1018961010100, ABEVMY 25MG ML BEVACIZUMAB INJECTION ; PRODUCTO: ABEVMY-BEVACIZUMAB, ORIGEN: BIOTECNOLOGIA MEDIANTE EL EMPLEO DE CELULAS DE OVARIO DE HAMSTER CHINO CELULAS CHO , ASPECTO FISICO: SOLUCI N CONCENTRADA PARA INFUSI N, TIPO DE EMPAQUE: PRESENTACI N DEL PRODUCTO: CAJA POR 1 VIAL DE VIDRIO TIPO I CON TAP N DE CLOROBUTILO DE 100 MG 4ML, USO: HUMANO, MARCA: ABEVMY, NOMBRE DEL LABORATORIO FABRICANTE: BIOCON BIOLOGICS INDIA LIMITED, DIRECCI N DEL LABORATORIO FABRICANTE: SPECIAL ECONOMIC ZONE PLOT NO- 2,3,4 5, PHASE IV, BOMMASANDRA-JIGANI LINK ROAD, BOMMASANDRA POST, BENGALURU - 560099, INDIA. NO. DE RESOLUCI N INVIMA DE BPM 2023006925 DE 24-FEB-23. CERTIFICADO BPM NO. 26543 DE 2020-05-14, USO: COMERCIAL. RS INVIMA 2023MBT-0000073, EXP 20195592, PO: INDIA LOTE: BF24007735 CANT 3500 U PEDIDO ITEM: 1065810304 Expand

Trade date 2025/05/27 B/L No. 92003004090009
Suppliers qalys pharmaceutical llc Buyers strenuus marketing s a s
POLs —— PODs bogota
Supply area United States Purchas area Colombia
Weight 130kg Amount 85000
Hs code 3002151000 Product tags immunological products
Product description DO 2508674 PEDIDO TRAMITE: 125-14005946 DECLARACION 1-1 ACTA DE REEMPAQUE: 2025136255 CON FECHA: 08 04 2025. ITEM 1 MCIA DE PRIMERA CALIDAD. NOMBRE DEL PRODUCTO: OGIVRI; NOMBRE DEL PRINCIPIO ACTIVO: TRASTUZUMAB, CONCENTRACION: CADA VIAL CONTIENE 440 MGDE TRASTUZUMAB, INDICACIONES Y O USO TERAP UTICO: C NCER DE MAMA C NCER DE MAMA METAST SICO CMM : OGIVRI TRASTUZUMAB EST INDICADO PARA EL TRATAMIENTO DE PACIENTES CON CMM CON SOBREEXPRESI N DE HER2: EN MONOTERAPIA EN LOS QUE HAYAN RECIBIDO PREVIAMENTE UNO O M S REG MENES DE QUIMIOTERAPIA COMO TRATAMIENTO DEL C NCER METAST SICO; EN COMBINACI N CON PACLITAXEL O DOCETAXEL EN LOS QUE NO HAYAN RECIBIDO PREVIAMENTE QUIMIOTERAPIA COMO TRATAMIENTO DEL C NCER METAST SICO; EN COMBINACI N CON UN INHIBIDOR DE LAAROMATASA PARA EL TRATAMIENTO DE PACIENTES CON CMM CON RECEPTORES HORMONALES. C NCER DE MAMA PRECOZ CMP : OGIVRI TRASTUZUMAB EST INDICADO EN EL TRATAMIENTO DE PACIENTES CON C NCER DE MAMA PRECOZ CMP HER2- POSITIVO: DESPU S DE LA CIRUG A, LA QUIMIOTERAPIA NEOADYUVANT Expand

Trade date 2025/04/08 B/L No. 92003002734345
Suppliers qalys pharmaceutical llc Buyers strenuus marketing s a s
POLs —— PODs bogota
Supply area United States Purchas area Colombia
Weight 172.44kg Amount 169566
Hs code 3002151000 Product tags immunological products
Product description DO 2506187 PEDIDO TRAMITE: FULPHILA 235 BLR 91392711 DECLARACION(1-1) (ITEM 2) FULPHILA (PEGFILGASTRIM) SOL 6MG/0.6ML PF Expand

+View All

Partners

Total 19

Rank Company Transactions Per Detail
1 strenuus llc united statessupplier,they trade on 2022-08-26 182 32.21% >
2 strenuus pharmaceutical marketing germanysupplier,they trade on 2021-10-29 119 21.06% >
3 strenuus marketing s a s colombiabuyer,they trade on 2021-12-27 104 18.41% >
4 qalys pharma llc othersupplier,they trade on 2024-10-03 44 7.79% >
5 brooks laboratories ltd. indiabuyer,they trade on 2021-08-31 36 6.37% >

+View All

Products

Total 8

Products Transactions Per Detail
immunological products
26 50% >
antisera
7 13.46% >
equipped with fixed dose drug
7 13.46% >
anesthetic
2 3.85% >
drug
2 3.85% >

+View All

Hscode rank

Total 54

HSCode Name Transactions Per Detail
HS 3002151000 26 50% >
HS 3002121900 7 13.46% >
HS 3004902400 7 13.46% >
HS 9018909090 5 9.62% >
HS 3004902100 2 3.85% >

+View All

Trading Area

Total 16

Area Transactions Per Detail
united states 257 45.49% >
other 78 13.81% >
india 74 13.1% >
germany 54 9.56% >
costa rica 41 7.26% >

+View All

Port statistics

Total 1

Port Name Transactions Per Detail
bogota 69 12.23% >

strenuus marketing s a s is International Buyer&Supplier, and primarily engages in the import and export business of products such as immunological products，antisera，equipped with fixed dose drug. According to the 52wmb.com global trade database, as of 2026-01-15, the company has completed 692 international trades, with its main trading regions covering united states，other,india etc. The core products include HS3002151000，HS3002121900，HS3004902400 etc, often transported via bogota etc, and its main trading partners are strenuus llc，strenuus pharmaceutical marketing，strenuus marketing s a s. These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing. They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development. They provide reliable support for cross-border trade decision-making.

The trade data displayed on strenuus marketing s a s is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis. We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.

Reference contact info

Email Hunting Tool

Employee emails